Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Five Prime Thera (NQ: FPRX )

38.00 USD UNCHANGED
Streaming Delayed Price Updated: 5:46 PM EDT, Apr 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Five Prime Thera

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Why Phase 2 Trials Are Important To Investors (And Why I’m Enrolled In One)
The biotech sector tends to attract investors who are interested in exciting new medical advances and are drawn to big profits. There are lots of ways to invest in the sector. 
Tags Market News Pharma/Biotech Healthcare
From Blogs - TalkMarkets
8 Retirement Stocks to Buy for Any Market Conditions
InvestorPlace - Stock Market News, Stock Advice & Trading Tips 2020 shows that investors need to be prepared for anything. These eight retirement stocks can do precisely that. The post 8 Retirement... 
Tags BUD CPB GE
From InvestorPlace
The Secret To Successful Biotech Investing
As we advance in years, more people get sick and require more medicines for difficult-to-treat diseases. So if I could invest in only one sector for the next five or ten years, it would be biotech. But... 
Tags Stocks / Equities Pharma/Biotech Market News
From Blogs - TalkMarkets
Is Amgen's Acquisition of Five Prime a Good Move for the Big Biotech?
The drugmaker needs as much potential revenue as it can acquire at a reasonable price. 
Tags ZLAB AMGN FPRX
From Motley Fool
Best Stocks To Invest In Right Now? 4 Biotech Stocks To Know
Tags Market News
From StockMarket.com
Though Potential Bidders Moved Away, Amgen's Bid For Five Prime Outlasted 15 Suitors
Earlier this month, biotech giantAmgen Inc(NASDAQ:AMGN)announced a $1.9 billion buyoutofFive Prime ... 
Tags General FDA Health Care
From Benzinga
The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FDA JNCE AFMD
From Benzinga
Earnings Scheduled For March 10, 2021
Companies Reporting Before The Bell • BioDelivery Sciences Intl (NASDAQ:BDSI) is estimated to report quarterly ... 
Tags HARP Earnings Scheduled HOFV
From Benzinga
Biotech stocks are a buy — especially these 18 picks
The sector's recent pullback offers an chance to get into exciting areas of biotech research like gene editing and oncology at better prices. 
Tags XBI PRTA NTLA
From MarketWatch
Earnings Outlook for Five Prime Therapeutics
Five Prime Therapeutics (NASDAQ:FPRX) releases its next round of earnings this Wednesday, March 10. Get the latest predictions in ... 
Tags Earnings BZI/EP Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2021
Upgrades ScotiaBank upgraded the previous rating for Primo Water Corp (NYSE:PRMW) from Sector Perform to Outperform. ... 
Tags Initiation LDI DHT
From Benzinga
The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings
Biotech stocks continued to move southward in the week ended March 5, as the broader market extended its sell-off. Though light on news, ... 
Tags XERS Penny Stocks DMAC
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 5, 2021
Upgrades For Boeing Co (NYSE:BA), Canaccord Genuity upgraded the previous rating of Hold to Buy. In the fourth quarter, ... 
Tags MIST BALY FI
From Benzinga
82 Biggest Movers From Yesterday
Gainers Five Prime Therapeutics, Inc. (NASDAQ: FPRX) shares surged 78.7% to close at $38.00 on Thursday after Amgen announced ... 
Tags Movers From Yesterday PRFX SDGR
From Benzinga
Notable Thursday Option Activity: FPRX, ZM, VECO
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Five Prime Therapeutics, Inc (FPRX), where a total volume of 34,643 contracts has... 
Tags Stocks
From Market News Video
Mid-Afternoon Market Update: Nasdaq Tumbles Over 200 Points; Five Prime Therapeutics Shares Spike Higher
Toward the end of trading Thursday, the Dow traded down 1.07% to 30,935.46 while the NASDAQ fell 1.64% to 12,784.21. The S&P also ... 
Tags Small Cap WTI Earnings
From Benzinga
Amgen to Buy Oncology Start-Up Five Prime Therapeutics for $1.9 Billion
The big biotech wants to bolster its late-stage pipeline with a potential new stomach cancer treatment. 
Tags AMGN FPRX Market News
From Motley Fool
Mid-Day Market Update: Dow Turns Positive; Schrödinger Shares Plummet
Midway through trading Thursday, the Dow traded up 0.11% to 31,304.43 while the NASDAQ fell 0.05% to 12,990.83. The S&P also fell, ... 
Tags Eurozone Commodities Penny Stocks
From Benzinga
Stocks Mixed Ahead of Powell's Bond Yields Update
Better-than-expected jobs data is giving sentiment a lift. 
Tags Stocks / Equities Market News
From Blogs - TalkMarkets
45 Stocks Moving In Thursday's Mid-Day Session
Gainers Five Prime Therapeutics, Inc. (NASDAQ: FPRX) shares jumped 78% to $37.85 after Amgen announced plans to acquire the ... 
Tags SDGR SLRX RRGB
From Benzinga
Why Five Prime Therapeutics Stock Is Skyrocketing Today
Amgen is paying a premium to buy the small biotech. 
Tags AMGN FPRX Market News
From Motley Fool
FPRX Stock: The Huge Takeover News That Has Five Prime Therapeutics Shares Blasting Higher
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Five Prime Therapeutics (FPRX) stock is soaring higher on Thursday... 
Tags AMGN Market News NASDAQ:FPRX,NASDAQ:AMGN
From InvestorPlace
Amgen Pays $1.9B For Five Prime Therapeutics Acquisition
Amgen Inc(NASDAQ:AMGN)has agreed to acquireFive Prime Therapeutics Inc(NASDAQ:FPRX) for $38 per ... 
Tags AMGN Benzinga Small Cap
From Benzinga
Mid-Morning Market Update: Markets Open Lower; Kroger Posts Mixed Q4 Results
Following the market opening Thursday, the Dow traded down 0.22% to 31,202.42 while the NASDAQ fell 1.6% to 12,790.20. The S&P also ... 
Tags Small Cap Earnings WTI
From Benzinga
Five Prime Therapeutics Stock Rockets On Amgen's $1.9 Billion Takeover
Amgen said Thursday it will spend $1.9 billion to buy Five Prime Therapeutics, a small biotech company with a promising stomach cancer drug. The news sent FPRX stock rocketing. 
From Investor's Business Daily
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags DRNA ORGO MRK
From Benzinga
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SRPT BMRN ICLR
From Benzinga
We Did The Math PBE Can Go To $82
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Market News RGEN HALO
From Benzinga
First Week of January 15th Options Trading For Five Prime Therapeutics (FPRX)
Investors in Five Prime Therapeutics, Inc (FPRX) saw new options become available this week, for the January 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.